On the mBC Phase 1/2 clinical trial in combination trial.
"This trial will be initiated once GMP RC220 is available, and after the completion of toxicology studies, ethics submission, and regulatory approvals. The expected timeframe for trial commencement is Q3 CY 2024."
Another 12 months before recruitment begins...
Ann: Race Strategic Update August 2023, page-7
-
- There are more pages in this discussion • 586 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.045(2.86%) |
Mkt cap ! $260.8M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.59 | $1.51 | $157.3K | 101.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3901 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.54 | 1000 | 1 |
View Market Depth
| Last trade - 13.53pm 11/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |